Increased Outsourcing Driving Investments in CRO Industry

Miller,Jim;

CONTINUE TO SITE

OR WAIT null SECS

Spotlight

Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems

AnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems

Topic

View More COVID-19 Update Analytical Method Development APIs Aseptic Processing Biologic Drugs Drug Delivery Equipment Excipients Formulation Packaging Process Control/PAT Process Development QA/QC Regulatory Action Supply Chain

COVID-19 UpdateAnalytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain

News

All News Bio/Pharma News

Publications

All Publications PharmTech PharmTech Europe

All PublicationsPharmTechPharmTech Europe

Multimedia

All Videos Ask the Expert Behind The Headlines Drug Digest Videos Drug Solutions Podcast

All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast

Conferences

Conference Coverage Conference Listing

Webcasts

Resources

ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Partners Peer-Reviewed Research Pharma Insights PharmTech Products Sponsored eBooks Sponsored Podcasts Sponsored Videos State of the Science Whitepapers

ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharma InsightsPharmTech ProductsSponsored eBooksSponsored PodcastsSponsored VideosState of the ScienceWhitepapers

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Increased Outsourcing Driving Investments in CRO Industry

Published on: August 2, 2004

Jim Miller

Pharmaceutical Technology, Pharmaceutical Technology-08-02-2004, Volume 28, Issue 8

The contract services industry is fertile ground for the investment banking community this summer.

Women in STEM: Inspiration from Innovators in Pharma

Cellares Secures $257M to Scale Global Cell Therapy Manufacturing

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases